These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31341723)

  • 21. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.
    Venkatesh SK; Wang G; Lim SG; Wee A
    Eur Radiol; 2014 Jan; 24(1):70-8. PubMed ID: 23928932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.
    Lefebvre T; Wartelle-Bladou C; Wong P; Sebastiani G; Giard JM; Castel H; Murphy-Lavallée J; Olivié D; Ilinca A; Sylvestre MP; Gilbert G; Gao ZH; Nguyen BN; Cloutier G; Tang A
    Eur Radiol; 2019 Dec; 29(12):6477-6488. PubMed ID: 31278577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
    Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
    J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of magnetic resonance elastography (MRE) to biomarker testing for staging fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Kaplan JM; Alexis J; Grimaldi G; Islam M; Izard SM; Lee TP
    Transl Gastroenterol Hepatol; 2023; 8():7. PubMed ID: 36704653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Long MT; Noureddin M; Lim JK
    Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
    Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
    J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal Ultrasound Combined with Laboratory Tests as a Reliable, Easily Accessible and Cost-Effective Way of Assessing the Stages of Liver Fibrosis and Cirrhosis.
    Montazeri G; Rohban N; Sotoudeh M; Massarrat S
    Arch Iran Med; 2022 Feb; 25(2):118-123. PubMed ID: 35429949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers.
    Besa C; Wagner M; Lo G; Gordic S; Chatterji M; Kennedy P; Stueck A; Thung S; Babb J; Smith A; Taouli B
    J Magn Reson Imaging; 2018 Jun; 47(6):1552-1561. PubMed ID: 29193508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
    Bonekamp S; Kamel I; Solga S; Clark J
    J Hepatol; 2009 Jan; 50(1):17-35. PubMed ID: 19022517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive assessment of hepatic fibrosis: comparison of MR elastography to transient elastography and intravoxel incoherent motion diffusion-weighted MRI.
    Fu F; Li X; Chen C; Bai Y; Liu Q; Shi D; Sang J; Wang K; Wang M
    Abdom Radiol (NY); 2020 Jan; 45(1):73-82. PubMed ID: 31372777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort.
    Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M
    Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
    Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of non-invasive tests for assessment of liver fibrosis.
    Patel K; Sebastiani G
    JHEP Rep; 2020 Apr; 2(2):100067. PubMed ID: 32118201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.
    Singh S; Venkatesh SK; Wang Z; Miller FH; Motosugi U; Low RN; Hassanein T; Asbach P; Godfrey EM; Yin M; Chen J; Keaveny AP; Bridges M; Bohte A; Murad MH; Lomas DJ; Talwalkar JA; Ehman RL
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):440-451.e6. PubMed ID: 25305349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of Hepatic Fibrosis.
    Mathew RP; Venkatesh SK
    Curr Gastroenterol Rep; 2018 Aug; 20(10):45. PubMed ID: 30159792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastography.
    Forsgren MF; Nasr P; Karlsson M; Dahlström N; Norén B; Ignatova S; Sinkus R; Cedersund G; Leinhard OD; Ekstedt M; Kechagias S; Lundberg P
    Scand J Gastroenterol; 2020 Jul; 55(7):848-859. PubMed ID: 32684060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR elastography in primary sclerosing cholangitis: a pictorial review.
    Welle CL; Navin PJ; Olson MC; Hoodeshenas S; Torbenson MS; Venkatesh SK
    Abdom Radiol (NY); 2023 Jan; 48(1):63-78. PubMed ID: 35567617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions.
    Srinivasa Babu A; Wells ML; Teytelboym OM; Mackey JE; Miller FH; Yeh BM; Ehman RL; Venkatesh SK
    Radiographics; 2016; 36(7):1987-2006. PubMed ID: 27689833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Intermethod Agreement and Fibrosis Stage Discriminative Performance.
    Cunha GM; Delgado TI; Middleton MS; Liew S; Henderson WC; Batakis D; Wang K; Loomba R; Huss RS; Myers RP; Sirlin CB; Fowler KJ; Hasenstab KA
    AJR Am J Roentgenol; 2022 Aug; 219(2):224-232. PubMed ID: 35107306
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
    Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
    J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.